immunotherapeutic combinations for mrcc: immotion-151
Published 6 years ago • 285 plays • Length 7:49Download video MP4
Download video MP3
Similar videos
-
8:07
vegf tki immunotherapy combinations for mrcc
-
1:49
dr. mcgregor on immunotherapy combinations in kidney cancer
-
3:45
combination immunotherapy in newly diagnosed mrcc
-
7:20
emerging immunotherapy combinations in kidney cancer
-
9:05
mrcc: when is tki/i-o combination therapy appropriate?
-
1:16
dr. mcgregor on combination therapies with nivolumab, cabozantinib, and sunitinib in rcc
-
5:11
selecting immunotherapy versus vegf tki for mrcc
-
0:48
rationale for combining atezolizumab/bevacizumab in mrcc
-
3:15
tki/i-o therapy in mrcc
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
1:32
dr. cohen on immunotherapy combinations in head and neck cancer
-
4:34
immunotherapy in renal cell carcinoma
-
1:51
dr. choueiri on ongoing trials of immunotherapy in rcc
-
1:14
combining immunotherapy with antiangiogenesis in rcc
-
6:56
role of tkis in intermediate or poor-risk mrcc
-
7:54
combination therapies in renal cell carcinoma
-
4:20
trial updates in mrcc from asco: keynote-427, resort, e2810 & immotion151
-
4:42
making decisions for second-line therapy in mrcc
-
1:47
dr. choueiri discusses avelumab/axitinib data in rcc